Guy MacDonald's Net Worth
$6.99 Million
Who is Guy MacDonald?
Guy MacDonald has an estimated net worth of $6.99 Million. This is based on reported shares across multiple companies, which include TETRAPHASE PHARMACEUTICALS INC, SCYNEXIS INC, and IDENIX PHARMACEUTICALS INC.
SEC CIK
Guy MacDonald's CIK is 0001296998
Past Insider Trading and Trends
2015 was Guy MacDonald's most active year for acquiring shares with 23 total transactions. Guy MacDonald's most active month to acquire stocks was the month of December. 2015 was Guy MacDonald's most active year for disposing of shares, totalling 26 transactions. Guy MacDonald's most active month to dispose stocks was the month of May. 2015 saw Guy MacDonald paying a total of $812,584.33 for 432,909 shares, this is the most they've acquired in one year. In 2015 Guy MacDonald cashed out on 284,357 shares for a total of $6,942,166.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TETRAPHASE PHARMACEUTICALS INC No price found
President and Chief Executive
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -15.70K |
—
|
—
|
0
|
Jul 28
| |||
Form 4
| -96.81% | -7.61K |
$2.27 | -$17,279.58 | 250.4 |
Dec 5 - Dec 6
| |||
Form 4
| +4.18% | 5.39K |
—
|
—
| 134.4K |
May 14 - Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
| +3.75% | 4.67K |
—
|
—
| 129.01K |
May 12 - Jan 19
| |||
Form 4
| +32.33% | 30.38K |
$2.90 | $88,096.20 | 124.34K |
Feb 9
| |||
Form 4
| +3.53% | 3.2K |
—
|
—
| 93.96K |
Nov 14 - Jan 31
| |||
Form 4
| +38.70% | 25.32K |
$0.87 | $22,031.01 | 90.76K |
May 16
| |||
Form 4
| +23.08% | 12K |
$0.87 | $10,440.00 | 64K |
Jan 6
| |||
Form 4
|
—
|
0
|
$24.76 | -$336,300.00 | 52K |
Scheduled
|
Sep 1
| ||
Form 4
| +30.00% | 12K |
$0.87 | $10,440.00 | 52K |
Aug 24
| |||
Form 4
| -42.86% | -30.00K |
$43.65 | -$1,309,500.00 | 40K |
Scheduled
|
Aug 6
| ||
Form 4
|
—
|
0
|
$27.70 | -$395,100.00 | 70K |
Scheduled
|
Aug 3
| ||
Form 4
| -17.65% | -15.00K |
$50.72 | -$760,800.00 | 70K |
Scheduled
|
Jul 20
| ||
Form 4
|
—
|
0
|
$27.93 | -$399,800.00 | 85K |
Scheduled
|
Jul 1
| ||
Form 4
| +19.57% | 13.91K |
$22.56 | -$577,032.26 | 85K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$24.73 | -$671,400.00 | 70.54K |
Scheduled
|
May 11
| ||
Form 4
| +39.57% | 20K |
$0.87 | $17,400.00 | 70.54K |
Mar 26
| |||
Form 4
|
—
|
0
|
$23.80 | -$317,146.00 | 50.54K |
Scheduled
|
Mar 2
| ||
Form 4
|
—
|
0
|
$21.62 | -$273,516.00 | 50K |
Scheduled
|
Feb 2
| ||
Form 4
|
—
|
0
|
$20.23 | -$1,116,828.01 | 50K |
Scheduled
|
Jan 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
$10.25 | -$164,360.00 | 50K |
Scheduled
|
Sep 23
| ||
Form 4
|
—
|
0
|
$9.44 | -$171,300.00 | 50K |
Scheduled
|
Sep 17
| ||
Form 4
|
—
|
0
|
$6.23 | -$107,200.00 | 50K |
Scheduled
|
Aug 20
| ||
Form 4
| +100.00% | 25K |
$0.87 | $21,750.00 | 50K |
Aug 5
| |||
Form 4
|
∞
| 25K |
$5.74 | -$124,302.00 | 25K |
Scheduled
|
Jul 18
| ||
Form 4
|
—
|
0
|
$6.57 | -$171,175.50 |
0
|
Scheduled
|
Jun 17
| ||
Form 4
|
—
|
0
|
$4.93 | -$121,950.00 |
0
|
Scheduled
|
May 19
| ||
Form 4
|
—
|
0
|
$5.28 | -$132,300.00 |
0
|
Scheduled
|
Apr 14
| ||
Form 4
|
—
|
0
|
$7.65 | -$203,250.00 |
0
|
Scheduled
|
Feb 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SCYNEXIS INC (SCYX) Snapshot price: $1.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +71.88% | 23K |
—
|
—
| 55K |
Jun 20
| |||
Form 4
| +45.45% | 10K |
—
|
—
| 32K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +83.33% | 10K |
—
|
—
| 22K |
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
| +200.00% | 8K |
$6.25 | $50,000.00 | 12K |
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
∞
| 40K |
$2.39 | $95,600.00 | 40K |
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IDENIX PHARMACEUTICALS INC No price found
Executive VP, Operations
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
∞
| 10K |
$14.00 | $140,000.00 | 10K |
Feb 2 - Jul 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||